Royal London Asset Management
IRWD icon

Royal London Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Royal London Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-211,589
Closed -$1.83M – 663
2018
Q4 		$1.83M Buy
211,589
+56,062
+36% +$643K 0.02% 601
2018
Q3 		$2.4M Sell
155,527
-10,535
-6% -$167K 0.02% 455
2018
Q2 		$2.66M Buy
+166,062
New +$2.46M 0.03% 497

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Royal London Asset Management's IRWD Position: Q1 2019 in Review

Royal London Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2019, closing a stake of 211,589 shares — an estimated $1.83M sold.

Royal London Asset Management first reported a position in IRWD in Q2 2018 and held it in 3 quarters. The position peaked at $2.66M in Q2 2018. 156 funds tracked by Wall St. Rank hold IRWD as of Q1 2019.

  • Royal London Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Royal London Asset Management sold 211,589 Ironwood Pharmaceuticals shares in Q1 2019, an estimated $1.83M.
  • Royal London Asset Management first reported a position in Ironwood Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Royal London Asset Management's Ironwood Pharmaceuticals position peaked at $2.66M in Q2 2018.
  • 156 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2019.

Based on Royal London Asset Management's 13F filing for Q1 2019, filed 30 Apr 2019.